A Study of RO5509554 as Monotherapy and in Combination With Paclitaxel in Participants With Advanced Solid Tumors

NCT01494688 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

217

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: Paclitaxel
DRUG: RO5509554

Sponsor

Hoffmann-La Roche